1. OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients. (18th December 2013) Authors: Koren‐Michowitz, Maya; Buzaglo, Zehavit; Ribakovsky, Elena; Schwarz, Michaela; Pessach, Ilias; Shimoni, Avichai; Beider, Katia; Amariglio, Ninette; Ie Coutre, Philipp; Nagler, Arnon Journal: European journal of haematology Issue: Volume 92:Number 4(2014:Apr.) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗